MEGAN CLEMENCE: Open Payments
NPI 1457911281 · CLARKSTON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$937 in 50 payments from 11 companies in 2025. Trend: 2023 $546 · 2024 $479 · 2025 $937
Food & beverage: $937
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $324 |
| Lilly USA, LLC | 9 | $164 |
| Amgen Inc. | 6 | $119 |
| GlaxoSmithKline, LLC. | 4 | $82 |
| PFIZER INC. | 4 | $72 |
| AstraZeneca Pharmaceuticals LP | 4 | $62 |
| Novartis Pharmaceuticals Corporation | 1 | $32 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| ABBVIE INC. | 1 | $19 |
Products named: Rybelsus, MOUNJARO, Wegovy, ELIQUIS, Ozempic, KRYSTEXXA, OTEZLA, AREXVY.
Industry payments across MI — which companies pay providers there.
